Utilization of MAsS in Patients Undergoing LT for HCC

NCT05184283 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 11

Last updated 2023-12-07

No results posted yet for this study

Summary

The aim of this study is to determine the effects of liver transplantation and standard immunosuppression on body composition in patients with compensated cirrhosis and hepatocellular carcinoma.

Conditions

Sponsors & Collaborators

Principal Investigators

  • Julia Wattacheril, MD · Columbia University Irving Medical Center/ New York Presbyterian hospital

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-06-16
Primary Completion
2023-11-29
Completion
2023-11-29

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05184283 on ClinicalTrials.gov